Glioblastoma cells release factors that disrupt blood-brain barrier features

Overview of attention for article published in Acta Neuropathologica, January 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

patent: 6 patents

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 154 Dimensions

Readers on

mendeley: 150 Mendeley
citeulike: 1 CiteULike

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 6 patents that reference this research output.

Dosing regimen for GP100-specific TCR—anti-CD3 SCFV fusion protein

Grant US-11827688-B2

United States of America

Method for permeabilizing tumor vasculature using a tumor vasculature permeabilizing…

Grant US-11744877-B2

United States of America

COMPOSITIONS FOR THE TREATMENT OF GLIOBLASTOMA

Application WO-2023094581-A1

World Intellectual Property Organisation (WIPO)

2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors

Grant US-8993573-B2

United States of America

2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors

Grant US-8835435-B2

United States of America

PRODUCT AND METHOD FOR PERMEABILISATION OF TUMOR VASCULATURE

Application US-20130101550-A1

United States of America